Wael Jaber, MD, chair of the 2025 American Society of Nuclear Cardiology annual meeting, shared some key takeaways from the conference. “This is no longer just about imaging for coronary disease," he explained. "Nuclear cardiology now helps guide therapy across a wide range of conditions."

Plaintiff attorneys claim the Massachusetts-based company shattered the competitive position of Pylarify, a PET imaging agent for prostate cancer. 

Founded in 2011 and based in Belgium, the AI firm offers the first software for automating brain assessments needed to administer disease therapies from Biogen and Eli Lilly. 

Biparametric prostate MRIs take significantly less time than multiparametric exams, as they do not include a contrast-enhanced sequence. This also makes the abbreviated exams more cost-friendly. 

New data align with a rise in intrigue around bedside point-of-care ultrasound to address growing patient demand. 

Using an advanced MRI technique, experts were able to measure tissue susceptibility and detect subtle variances in iron levels throughout different regions of the brain associated with memory.

The system enables surgeons to intraoperatively illuminate cancerous tissue in the breast cavity during lumpectomy surgery.

Evaluating LVDF with echocardiography or AI-powered electrocardiography can help identify individuals at an increased risk of developing atrial fibrillation, according to new data presented at the ASE 36th Annual Scientific Sessions.